1. Home
  2. Clinical Topics
  3. FDA approves Tivicay for HIV infection
Clinical TopicsDrugs and DevicesWeb Exclusives

FDA approves Tivicay for HIV infection

Share

On August 12, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts